https://www.medrxiv.org/content/10.1101/2021.03.03.21251066v1.full
Methods We conducted a cohort study with two age groups, young vaccinees below the age of 60 and elderly vaccinees over the age of 80, to compare their antibody responses to the first and second dose of the BNT162b2 COVID-19 vaccination.